MedMen Enterprises announced the close of a $67 million deal with Florida-based private company Green Sentry Holdings for its Florida-based operations, including its license, dispensaries, inventory and cultivation operations.
The deal is comprised of $63 million in cash and approximately $4 million in liabilities to be assumed by Green Sentry. The deal also includes the license of MedMen’s trademarks in the state.
“We are pleased to announce the successful completion of this deal, particularly given the challenging economic environment we are operating in,” said MedMen CEO Ed Record. “The sale of MedMen’s Florida assets marks an important step in the company’s restructuring efforts designed to provide greater financial flexibility and a stronger, leaner operating structure – and ultimately put us on a path to being EBITDA positive.”
MedMen also announced it’s currently exploring strategic alternatives for New York, where it operates a cultivation facility and four dispensaries under the state’s existing medical program. MedMen's operational footprint is primed to benefit from the pending rollout of recreational sales in New York.
Added Record, “We are focused on maximizing our existing footprint, including our operations in New York. New York’s adult-use market will be game-changing for the entire industry, and we are considering all options to ensure strong shareholder return. This includes the potential sale of assets and/or licensing of the MedMen trademark," said Record.
